Contrast Media

Galt Medical, Health Line International Corp., Nexus CT Midline Catheter with MST Insertion Kit

Image courtesy of Galt Medical

Technology | Contrast Media Injectors | October 01, 2015
October 1, 2015 — Galt Medical has partnered with Health Line International Corp.
EMI-137, optical imaging agent, detection, early stage, colorectal cancer
News | Oncology Diagnostics | September 18, 2015
Edinburgh Molecular Imaging Ltd. (EM Imaging) has signed an exclusive global license for a novel optical imaging agent...
UAMS, Vladimir Zharov, melanoma, theranostics, CTCs, nanoparticles
News | Ultrasound Imaging | September 14, 2015
September 14, 2015 — University of Arkansas for Medical Sciences (UAMS) researcher Vladimir Zharov, Ph.D., D.Sc., was
ultrasound, microbubbles, delivery, absorption, drugs, pancreatic cancer, ICUS
News | Contrast Media | September 11, 2015
Tiny gas microbubbles can enhance the delivery and absorption of cancer drugs in patients with advanced pancreatic...
NIH, biomarker, breast cancer, early detection, contrast solution, MRI

Metastasis occurs when cells are shed from primary breast cancer tumor and establish a new tumor at a distant site. For early detection of the metastasis with MRI, the Lu Lab developed a probe that binds to fibrin-fibronectin protein complexes in high-risk tumors. Fibronectin is expressed in high-risk (aggressive) cancer and not in normal tissue, so MRI imaging is able to distinguish metastases from normal tissue. Image courtesy of the National Institutes of Health.

News | MRI Breast | August 12, 2015
Researchers have shown that magnetic resonance imaging (MRI) can detect the earliest signs of breast cancer recurrence...
NIR, contrast agents, thyroid, parathyroids, surgery, Frangioni, FLARE

Intraoperative image of thyroid (red) and parathyroids (green) in rats four hours after intravenous injection of targeted contrast agents. Image captured using the FLARE system. Image courtesy of Macmillan Publishers Ltd.

News | Contrast Media | July 29, 2015
Researchers funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have developed two near-...
Guerbet, acquisition, Mallinckrodt, CMDS business, contrast media, CT, MRI
Feature | Contrast Media | July 28, 2015
Guerbet announced that it has entered into a definitive agreement under which it will acquire Mallinckrodt's contrast...
MRI, gadolinium, contrast agents, Wolters Kluwer, safety issue
Feature | Contrast Media | June 26, 2015
New results in animals highlight a major safety concern regarding a class of magnetic resonance imaging (MRI) contrast...
molecular MRI, contrast agents, PSMA, cancer, SNMMI, Sangeeta Ray
News | June 16, 2015
The prostate-specific membrane antigen (PSMA) biomarker is the bullseye for three new magnetic resonance imaging (MRI)...
Bracco, Lumason, first U.S. echocardiography procedure, Morristown
Feature | Contrast Media | June 04, 2015
Bracco Imaging announced that the first echocardiography imaging procedure with Lumason was performed in May at...
Visipaque, IOCM, LOCM, angioplasty, EuroPCR 2015
News | May 22, 2015
Significantly fewer renal and cardiac events are associated with angioplasty procedures using isosmolar contrast medium...
gadolinium, brain, contrast MRI, Radiology, Kanal
Feature | May 05, 2015
New research, published in the journal Radiology, suggests some types of a popular contrast agent used in magnetic...
Technology | March 06, 2015
Bracco Imaging, through its business unit Bracco Injeneering SA, announced the availability of its EmpowerCTA+, an...
nanoparticles, stroke, tPA, blood clot, magnetic, MRI, antiplatelet

Each nanoparticle is composed of an iron oxide core (red squares) that is swathed in albumin (grey) and the anti-clotting agent tPA (green). The iron oxide cubes are about 20 nm on a side.

News | February 26, 2015
By loading magnetic nanoparticles with drugs and dressing them in biochemical camouflage, Houston Methodist researchers...
MR guided focused ultrasound, Alzheimer's, mice, contrast media

The image on the left shows the plaque abnormalities on untreated transgenic mice and the image on the right shows the brain of a transgenic mouse that has been treated with MR imaging-guided focused ultrasound. Image courtesy of Kullervo Hynynen, Sunnybrook Research Institute.

Feature | February 13, 2015
For the first time, researchers have reversed some of the symptoms of Alzheimer’s disease in mice using magnetic...
Feature | February 10, 2015 | Raissa Rocha and Dave Fornell
There have been several recent advances with contrast media injector technology, including cutting costs by reducing...
Contrast media, Nuclear imaging, Radiopharmaceuticals and tracers

Image courtesy of Lantheus

News | January 30, 2015
Lantheus Medical Imaging Inc. announced an agreement with the Institute for Radioelements (IRE) for the future supply...
Nephrocheck Test System, Blood testing, contrast media

Image courtesy of Astute Medical

News | January 27, 2015
Ortho-Clinical Diagnostics Inc. announced the nationwide availability to hospitals of the Nephrocheck Test System...
Bayer Healthcare, Gadavist, FDA, approval, pediatric patients, contrast media

Image courtesy of Bayer Healthcare

Technology | January 06, 2015
Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol)...
Technology | December 23, 2014
Bayer unveiled version 2.5 of its Radimetrics Enterprise Platform at the 2014 Radiological Society of North America (...
Overlay Init